MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-12-2024
Vapotherm Operating Income 2011-2026 | VAPO
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Vapotherm
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -39.1 M | -100 M | -57.2 M | -43 M | -48.2 M | -37.2 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -37.2 M | -100 M | -54.2 M |
Quarterly Operating Income Vapotherm
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.27 M | -5.58 M | - | -10.3 M | -10.2 M | -13.6 M | - | -22.9 M | -39.8 M | -19.9 M | - | -12.9 M | -16.6 M | -9.7 M | -12.3 M | -11.2 M | -6.77 M | -12.7 M | -12.7 M | -11.6 M | -11.7 M | -12.1 M | -10.9 M | -8.73 M | -9.15 M | -8.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -5.58 M | -39.8 M | -13 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.11 | 8.21 % | $ 3.29 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 10.42 | -1.65 % | $ 1.41 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 12.6 | 2.61 % | $ 1.89 B | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 3.91 | 2.62 % | $ 828 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 8.38 | -0.24 % | $ 602 M |  Israel |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 69.79 | 0.95 % | $ 103 B | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.96 | 1.02 % | $ 148 M |  France |
 |
CONMED Corporation
CNMD
|
103 M | $ 37.41 | 0.35 % | $ 1.16 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.65 | -8.13 % | $ 35.4 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 11.03 | 2.22 % | $ 298 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-39 M | $ 63.48 | 0.21 % | $ 1.88 B |  Costa-rica |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.42 | 0.22 % | $ 121 M | USA |
 |
InMode Ltd.
INMD
|
85.4 M | $ 13.43 | -0.81 % | $ 868 M | Israel |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
8.05 B | $ 109.95 | 1.8 % | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 9.81 | 3.81 % | $ 351 M | USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 261.24 | -0.59 % | $ 7.37 B | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.19 | 3.79 % | $ 1.33 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.01 | -2.49 % | $ 694 M | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 32.84 | 1.55 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
608 M | $ 169.45 | 3.18 % | $ 12.7 B | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 32.76 | -2.93 % | $ 4.88 K | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.33 | 2.31 % | $ 21.5 M | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
-6.45 M | $ 3.67 | 1.1 % | $ 151 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 17.11 | -1.16 % | $ 401 M | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 84.12 | 1.34 % | $ 2.92 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |